Lemborexant is a pharmaceutical raw material used as an orexin receptor antagonist. It is a compound employed in the manufacturing of medications for the management of insomnia.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1369764-02-2
(1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropane-carboxylic acid
research reagent
Sacubitril calcium
pharmaceutical raw material
Pralidoxime chloride, (Z)-
pharmaceutical raw material
Lotilaner
pharmaceutical raw material
Lidocaine
pharmaceutical raw material
cis-(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropane-1-carboxamide
MUGXRYIUWFITCP-PGRDOPGGSA-N
CC1=NC(=NC=C1OC[C@]2(C[C@H]2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C